載入...
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial
OBJECTIVE: To estimate the incremental cost-effectiveness of infliximab versus conventional combination treatment over 21 months in patients with methotrexate-refractory early rheumatoid arthritis. METHODS: In this multicentre, two-arm, parallel, randomised, active-controlled, open-label trial, rheu...
Na minha lista:
| 發表在: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4431324/ https://ncbi.nlm.nih.gov/pubmed/24737786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-205060 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|